The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
In pharmaceutical continuous manufacturing technology, active ingredients are produced in compact, closed units, leveraging automation. Hence, it requires fewer manual interventions. Production steps carried out sequentially in a classic batch process are combined in a continuous process. All these help to bring about continued utilization of production capacity. This in turn serves to reduce fluctuations in production, improve yields, and lower costs of operation and equipment. On account of such advantages, the method is seeing fast adoption.
Global Pharmaceutical Continuous Manufacturing market is projected to reach US$ 2639.7 million in 2029, increasing from US$ 1820.8 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceutical Continuous Manufacturing market research.
Key companies engaged in the Pharmaceutical Continuous Manufacturing industry include Siemens, Corning Life Sciences, GEA Group, S K Biotek, Scott Equipment Company, Korsch, Continuus Pharmaceuticals and Chemtrix, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Pharmaceutical Continuous Manufacturing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pharmaceutical Continuous Manufacturing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pharmaceutical Continuous Manufacturing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company (Partial List):
- Siemens
- Corning Life Sciences
- GEA Group
- S K Biotek
- Scott Equipment Company
- Korsch
- Continuus Pharmaceuticals
- Chemtrix
Segment by Type
- Active Pharmaceutical Ingredient
- Biologics
- Dry Powders
Segment by Application
- Pharmaceutical Companies
- Contract Manufacturing Organization
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
The Pharmaceutical Continuous Manufacturing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Continuous Manufacturing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Active Pharmaceutical Ingredient
1.2.3 Biologics
1.2.4 Dry Powders
1.3 Market by Application
1.3.1 Global Pharmaceutical Continuous Manufacturing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Companies
1.3.3 Contract Manufacturing Organization
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Continuous Manufacturing Market Perspective (2018-2029)
2.2 Pharmaceutical Continuous Manufacturing Growth Trends by Region
2.2.1 Global Pharmaceutical Continuous Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pharmaceutical Continuous Manufacturing Historic Market Size by Region (2018-2023)
2.2.3 Pharmaceutical Continuous Manufacturing Forecasted Market Size by Region (2024-2029)
2.3 Pharmaceutical Continuous Manufacturing Market Dynamics
2.3.1 Pharmaceutical Continuous Manufacturing Industry Trends
2.3.2 Pharmaceutical Continuous Manufacturing Market Drivers
2.3.3 Pharmaceutical Continuous Manufacturing Market Challenges
2.3.4 Pharmaceutical Continuous Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Continuous Manufacturing Players by Revenue
3.1.1 Global Top Pharmaceutical Continuous Manufacturing Players by Revenue (2018-2023)
3.1.2 Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical Continuous Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Continuous Manufacturing Revenue
3.4 Global Pharmaceutical Continuous Manufacturing Market Concentration Ratio
3.4.1 Global Pharmaceutical Continuous Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Continuous Manufacturing Revenue in 2022
3.5 Pharmaceutical Continuous Manufacturing Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Continuous Manufacturing Product Solution and Service
3.7 Date of Enter into Pharmaceutical Continuous Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Continuous Manufacturing Breakdown Data by Type
4.1 Global Pharmaceutical Continuous Manufacturing Historic Market Size by Type (2018-2023)
4.2 Global Pharmaceutical Continuous Manufacturing Forecasted Market Size by Type (2024-2029)
5 Pharmaceutical Continuous Manufacturing Breakdown Data by Application
5.1 Global Pharmaceutical Continuous Manufacturing Historic Market Size by Application (2018-2023)
5.2 Global Pharmaceutical Continuous Manufacturing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pharmaceutical Continuous Manufacturing Market Size (2018-2029)
6.2 North America Pharmaceutical Continuous Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pharmaceutical Continuous Manufacturing Market Size by Country (2018-2023)
6.4 North America Pharmaceutical Continuous Manufacturing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Continuous Manufacturing Market Size (2018-2029)
7.2 Europe Pharmaceutical Continuous Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pharmaceutical Continuous Manufacturing Market Size by Country (2018-2023)
7.4 Europe Pharmaceutical Continuous Manufacturing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size (2018-2029)
8.2 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Region (2018-2023)
8.4 Asia-Pacific Pharmaceutical Continuous Manufacturing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Continuous Manufacturing Market Size (2018-2029)
9.2 Latin America Pharmaceutical Continuous Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pharmaceutical Continuous Manufacturing Market Size by Country (2018-2023)
9.4 Latin America Pharmaceutical Continuous Manufacturing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size (2018-2029)
10.2 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Country (2018-2023)
10.4 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens
11.1.1 Siemens Company Detail
11.1.2 Siemens Business Overview
11.1.3 Siemens Pharmaceutical Continuous Manufacturing Introduction
11.1.4 Siemens Revenue in Pharmaceutical Continuous Manufacturing Business (2018-2023)
11.1.5 Siemens Recent Development
11.2 Corning Life Sciences
11.2.1 Corning Life Sciences Company Detail
11.2.2 Corning Life Sciences Business Overview
11.2.3 Corning Life Sciences Pharmaceutical Continuous Manufacturing Introduction
11.2.4 Corning Life Sciences Revenue in Pharmaceutical Continuous Manufacturing Business (2018-2023)
11.2.5 Corning Life Sciences Recent Development
11.3 GEA Group
11.3.1 GEA Group Company Detail
11.3.2 GEA Group Business Overview
11.3.3 GEA Group Pharmaceutical Continuous Manufacturing Introduction
11.3.4 GEA Group Revenue in Pharmaceutical Continuous Manufacturing Business (2018-2023)
11.3.5 GEA Group Recent Development
11.4 S K Biotek
11.4.1 S K Biotek Company Detail
11.4.2 S K Biotek Business Overview
11.4.3 S K Biotek Pharmaceutical Continuous Manufacturing Introduction
11.4.4 S K Biotek Revenue in Pharmaceutical Continuous Manufacturing Business (2018-2023)
11.4.5 S K Biotek Recent Development
11.5 Scott Equipment Company
11.5.1 Scott Equipment Company Company Detail
11.5.2 Scott Equipment Company Business Overview
11.5.3 Scott Equipment Company Pharmaceutical Continuous Manufacturing Introduction
11.5.4 Scott Equipment Company Revenue in Pharmaceutical Continuous Manufacturing Business (2018-2023)
11.5.5 Scott Equipment Company Recent Development
11.6 Korsch
11.6.1 Korsch Company Detail
11.6.2 Korsch Business Overview
11.6.3 Korsch Pharmaceutical Continuous Manufacturing Introduction
11.6.4 Korsch Revenue in Pharmaceutical Continuous Manufacturing Business (2018-2023)
11.6.5 Korsch Recent Development
11.7 Continuus Pharmaceuticals
11.7.1 Continuus Pharmaceuticals Company Detail
11.7.2 Continuus Pharmaceuticals Business Overview
11.7.3 Continuus Pharmaceuticals Pharmaceutical Continuous Manufacturing Introduction
11.7.4 Continuus Pharmaceuticals Revenue in Pharmaceutical Continuous Manufacturing Business (2018-2023)
11.7.5 Continuus Pharmaceuticals Recent Development
11.8 Chemtrix
11.8.1 Chemtrix Company Detail
11.8.2 Chemtrix Business Overview
11.8.3 Chemtrix Pharmaceutical Continuous Manufacturing Introduction
11.8.4 Chemtrix Revenue in Pharmaceutical Continuous Manufacturing Business (2018-2023)
11.8.5 Chemtrix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
